239 related articles for article (PubMed ID: 22871634)
1. HIV integrase as a target for antiretroviral therapy.
Hazuda DJ
Curr Opin HIV AIDS; 2012 Sep; 7(5):383-9. PubMed ID: 22871634
[TBL] [Abstract][Full Text] [Related]
2. HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
[TBL] [Abstract][Full Text] [Related]
3. Integrase inhibitors in the treatment of HIV-1 infection.
Powderly WG
J Antimicrob Chemother; 2010 Dec; 65(12):2485-8. PubMed ID: 20852268
[TBL] [Abstract][Full Text] [Related]
4. Role of integrase inhibitors in the treatment of HIV disease.
Palmisano L
Expert Rev Anti Infect Ther; 2007 Feb; 5(1):67-75. PubMed ID: 17266455
[TBL] [Abstract][Full Text] [Related]
5. Integrase inhibitors for the treatment of HIV infection.
Pace P; Rowley M
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):471-9. PubMed ID: 18600564
[TBL] [Abstract][Full Text] [Related]
6. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
7. Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity.
Fun A; Van Baelen K; van Lelyveld SF; Schipper PJ; Stuyver LJ; Wensing AM; Nijhuis M
J Antimicrob Chemother; 2010 Nov; 65(11):2300-4. PubMed ID: 20736234
[TBL] [Abstract][Full Text] [Related]
8. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
Christ F; Debyser Z
Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
[TBL] [Abstract][Full Text] [Related]
9. Resistance to HIV-1 integrase inhibitors: A structural perspective.
Mouscadet JF; Delelis O; Marcelin AG; Tchertanov L
Drug Resist Updat; 2010; 13(4-5):139-50. PubMed ID: 20570551
[TBL] [Abstract][Full Text] [Related]
10. Biochemical screening assays to identify HIV-1 integrase inhibitors.
Clynhens M; Smets A; Vereycken I; Van Loock M; Clayton R; Meersseman G; Goethals O
Methods Mol Biol; 2013; 1030():25-36. PubMed ID: 23821258
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into the retroviral DNA integration apparatus.
Cherepanov P; Maertens GN; Hare S
Curr Opin Struct Biol; 2011 Apr; 21(2):249-56. PubMed ID: 21277766
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in the development of inhibitors of human immunodeficiency virus (HIV) integrase for the management of HIV infection.
Lin SS; Xu F; Liao PH; Yang CC
Acta Virol; 2008; 52(4):197-207. PubMed ID: 19143475
[TBL] [Abstract][Full Text] [Related]
13. Discovery and analysis of inhibitors of the human immunodeficiency integrase.
Hazuda D; Felock PJ; Hastings JC; Pramanik B; Wolfe AL
Drug Des Discov; 1997 May; 15(1):17-24. PubMed ID: 9332828
[TBL] [Abstract][Full Text] [Related]
14. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer.
Voet AR; Maeyer MD; Debyser Z; Christ F
Future Med Chem; 2009 Oct; 1(7):1259-74. PubMed ID: 21426102
[TBL] [Abstract][Full Text] [Related]
15. The future of integrase inhibitors of HIV-1.
Malet I; Calvez V; Marcelin AG
Curr Opin Virol; 2012 Oct; 2(5):580-7. PubMed ID: 22980926
[TBL] [Abstract][Full Text] [Related]
16. Novel integrase inhibitors for HIV.
Prada N; Markowitz M
Expert Opin Investig Drugs; 2010 Sep; 19(9):1087-98. PubMed ID: 20707594
[TBL] [Abstract][Full Text] [Related]
17. Integrase inhibitors to treat HIV/AIDS.
Pommier Y; Johnson AA; Marchand C
Nat Rev Drug Discov; 2005 Mar; 4(3):236-48. PubMed ID: 15729361
[TBL] [Abstract][Full Text] [Related]
18. Resistance to HIV integrase inhibitors.
Mesplède T; Quashie PK; Wainberg MA
Curr Opin HIV AIDS; 2012 Sep; 7(5):401-8. PubMed ID: 22789986
[TBL] [Abstract][Full Text] [Related]
19. [Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens].
Kravchenko AV
Ter Arkh; 2010; 82(11):27-32. PubMed ID: 21381345
[TBL] [Abstract][Full Text] [Related]
20. Resistance to novel drug classes.
Marcelin AG; Ceccherini-Silberstein F; Perno CF; Calvez V
Curr Opin HIV AIDS; 2009 Nov; 4(6):531-7. PubMed ID: 20048722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
